Off-patent Drugs Bill

Craig Williams Excerpts

Friday 6th November 2015 Commons Chamber

[Craig Williams (Cardiff North) (Con)]

It is a pleasure to follow my hon. Friend the Member for North Dorset (Simon Hoare). I commend the hon. Member for Torfaen (Nick Thomas-Symonds) for introducing the Bill and for paying tribute to my predecessor, Jonathan Evans, who tried to introduce a similar Bill in the previous Parliament. I shall be brief, but there are a couple of things I should like to add to the debate. I feel strongly about this Bill, and I am here debating it even though it means missing a meeting with my constituents. I am not sure how I can get an apology to them for that, but hopefully that explanation helps.

A number of charities back the Bill, which has cross-party support. I have served as the vice-chair of the all-party parliamentary group on these issues, and I want to pay tribute to Breast Cancer Now, which has given us terrific support. It pioneered the way and has guided us through the Bill. The hon. Member for Torfaen knows that better than I do.

I want to dwell on the licence gap and the points that have emerged about GPs and off-label prescriptions. Some clinicians and GPs, as well as the wider group of people who can prescribe, have confidence and belief in the drugs. I think it is more an issue of confidence than one of off-label. The big issue for me and my predecessor, Jonathan, is the postcode lottery. Some GPs know that there is access and which off-patent and off-label drugs they can heartily recommend to their patients, and they willingly prescribe them. However, there are some clinicians who will not do so.

[Antoinette Sandbach (Eddisbury) (Con)]

The chair of the breast cancer clinical reference group, Professor Ian Smith, joined 39 other eminent clinicians in pledging public support for the Bill last week. Does my hon. Friend agree that there is an identifiable problem, which is likely to arise, with the insurance liability for prescribers?

[Craig Williams]

My hon. Friend makes an excellent point, and adds to the body of evidence. That issue could be looked at further in Committee.

In closing, I want to add one point. This Government and the coalition Government set up the cancer drugs fund, on which I commend them. I only wish it was available in Wales. The Bill would enable that fund to be used to apply for cheaper drugs, which would mean that the money went a lot further. Although I will continue my campaign to get our dear friends the Welsh Labour Government to initiate a cancer drugs fund, I commend the Bill to the Minister as it would help to deliver that fund, and to do so far more cheaply and effectively.

I have teased out the off-patent, off-label issue as I wanted to do, and I hope the Minister takes that and my colleagues’ points on board to pull this sector and the charities together, regardless of what happens to the Bill. However, I commend the Bill, I thank the hon. Member for Torfaen for leading on it and I once again commend the work of my predecessor, Jonathan.